Medical devices and drugs are now among the potential battlegrounds if a trade war should erupt between China and the U.S. In the latest saber rattling, the U.S. Trade Representative (USTR) Tuesday proposed adding a 25 percent duty on about 1,300 products from China in retaliation for China's technology transfer, intellectual property and innovation policies that discriminate against U.S. commerce. Topping the list of products are more than three pages of active pharmaceutical ingredients (APIs), finished drugs, diagnostics and devices. Read More
